Delivery Order SPE2DB20D1109-SPE2DB25FP47M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Savella 100 mg tablets (60-count units) with a ceiling value of $4,750.50. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,526.28 contract is for the delivery of Savella 50 mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 tablets of the medication Savella 25 mg. The contract, valued at $1,149.00, has a completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,309.08 firm fixed price delivery order is for the supply of Savella 50 mg tablets. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,457,817 units of the pharmaceutical product SAVELLA 50 MG TABLET 60S. The contract has a potential value of $1,039.63 and a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA that has a potential value of up to $999,999,999.00 and a...
- This is a $1,306.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 60 tablets of the medication SAVELLA 50 MG. The contract has an ultimate completion date of June 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,592.96 firm fixed-price contract is for the delivery of SAVELLA 50 MG TABLET 60S, a medication, with a performance period ending on July 7, 2025. This order is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Savella 50 mg tablets, a medication used to treat fibromyalgia. The contract has a ceiling value of $2,733.67 and a completion date of June 18, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP47MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Savella (milnacipran) 100 mg tablets in a 60-count quantity. This is a firm fixed-price, non-set-aside contract with a ceiling value of $3,669.15 and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare supplies to military and veteran healthcare systems. This delivery order for Savella, a neurological treatment medication, reflects the company's extensive portfolio of specialized pharmaceutical products and its established capability to meet federal procurement requirements through competitive bidding. The award demonstrates the vendor's ongoing role in supporting the Defense Health Agency and other government healthcare systems through its flexible and comprehensive contract vehicles with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/28/25 |